Status | Study |
Completed |
Study Name: Phototoxicity Test of Dapsone Gel in Healthy Volunteers Condition: Healthy Volunteers Date: 2014-04-07 Interventions: Drug: dapsone gel Patches cont |
Completed |
Study Name: Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate Condition: Superficial Basal Cell Carcinoma Date: 2011-12-05 Interventions: Drug: Methylaminolevulinate PDT in 2 sessions |
Completed |
Study Name: A Study Evaluating Skin Irritation, Phototoxicity and Safety After Administration of LEO 90105 on Intact Skin of Healthy Japanese Male Subjects Condition: Healthy Date: 2011-02-09 Interventions: Drug: LEO 90105 Ointment |
Withdrawn |
Study Name: Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light Condition: High-grade Dysplasia in Barrett Esophagus Non Small Cell Lung Cancer Date: 2010-12-07 Interventions: Drug: Solar Protection Formula SPF® 60 |
Completed |
Study Name: TMC435-TiDP16-C125 - Study in Healthy Volunteers to Evaluate the Potential of TMC435 to Increase the Sensitivity of the Skin Towards Exposure to Sun Light Condition: Hepatitis C Virus Date: 2010-05-13 Interventions: Drug: TMC435 one morning TMC43 |
Completed |
Study Name: A Study to Evaluate the Potential of Tazarotene Foam to Cause a Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers Condition: Acne Vulgaris Date: 2010-04-30 Interventions: Drug: Tazarotene Foam without irradiation |
Completed |
Study Name: A Study to Evaluate the Photoirritation Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers Condition: Actinic Keratosis Date: 2009-02-23 Interventions: Drug: PEP005 (ingenol mebutate) Gel PEP005 (ingenol mebutate) Gel, 0.01% |
Completed |
Study Name: Clinical Evaluation of the Phototoxic Potential of Xenaderm Ointment Condition: Healthy Date: 2008-03-24 Interventions: Drug: Xenaderm 20mg under Finn |
Completed |
Study Name: Clinical Evaluation of the Photoallergy Potential of Atralin Gel Condition: Healthy Date: 2008-01-08 Interventions: Drug: Atralin (tretinoin) gel, 0.05% Assess photoallergic reactions for tretinoin 0.05% and vehicle, mea |
Completed |
Study Name: Phototoxicity Potential of NatrOVA Creme Rinse - 1% Condition: Head Lice Date: 2007-12-28 Interventions: Drug: Spinosad (the active ingredient in NatrOVA) |